Circulating Nucleic Acids as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is a particularly aggressive and deadly cancer, primarily due to failure to identify early-stage disease. PDAC is often diagnosed at a late stage due to nonspecific symptoms, and a distinct lack of reliable biomarkers for timely diagnosis. Curr...

Descripción completa

Detalles Bibliográficos
Autores principales: McGowan, Ryan, Sally, Áine, McCabe, Anthony, Moran, Brian Michael, Finn, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031361/
https://www.ncbi.nlm.nih.gov/pubmed/35454933
http://dx.doi.org/10.3390/cancers14082027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031361/
https://www.ncbi.nlm.nih.gov/pubmed/35454933
http://dx.doi.org/10.3390/cancers14082027

Ejemplares similares